The trading price of Silexion Therapeutics Corp (NASDAQ:SLXN) closed higher on Monday, February 10, and closing at $1.31, 3.97% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $1.2504 and $1.4099. In examining the 52-week price action we see that the stock hit a 52-week high of $122.02 and a 52-week low of $0.57. Over the past month, the stock has lost -32.47% in value.
Silexion Therapeutics Corp, whose market valuation is $5.23 million at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
A quick review shows that SLXN’s price is currently -3.15% off the SMA20 and -37.55% off the SMA50. The RSI metric on the 14-day chart is currently showing 45.59, and weekly volatility stands at 24.92%. When measured over the past 30 days, the indicator reaches 24.99%. Silexion Therapeutics Corp (NASDAQ:SLXN)’s beta value is currently sitting at 0.05, while the Average True Range indicator is currently displaying 0.45.
To see how Silexion Therapeutics Corp stock has been performing in comparison to its peers in the industry, here are the numbers: SLXN stock’s performance was 3.97% in the latest trading, and -98.57% in the past year.
An evaluation of the daily trading volume of Silexion Therapeutics Corp (NASDAQ:SLXN) indicates that the 3-month average is 11.38 million. However, this figure has increased over the past 10 days to an average of 61.85.
Currently, records show that 4.00 million of the company’s shares remain outstanding. The insiders hold 47.50% of outstanding shares, whereas institutions hold 11.73%. The stats also highlight that short interest as of 2024-11-15, stood at 35842.0 shares, resulting in a short ratio of 0.23 at that time. From this, we can conclude that short interest is 308.00 of the company’s total outstanding shares. It is noteworthy that short shares in November were up slightly from the previous month’s figure, which was 9885.0. However, since the stock’s price has seen -34.83% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
